| Serial Number | 97636862 |
| Word Mark | DEGEVMA |
| Filing Date | Tuesday, October 18, 2022 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, November 4, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 4, 2025 |
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 2, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | TEVA PHARMACEUTICALS USA, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Parsippany, NJ 07054 |
| Party Name | TEVA PHARMACEUTICALS USA, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Parsippany, NJ 07054 |
| Event Date | Event Description |
| Friday, October 21, 2022 | NEW APPLICATION ENTERED |
| Wednesday, November 2, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 28, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, March 28, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, March 28, 2023 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Wednesday, March 29, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 29, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, March 29, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sunday, July 16, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Sunday, July 16, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Monday, July 17, 2023 | TEAS PETITION TO REVIVE RECEIVED |
| Monday, July 17, 2023 | PETITION TO REVIVE-GRANTED |
| Tuesday, July 18, 2023 | NOTICE OF REVIVAL - E-MAILED |
| Thursday, September 5, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, September 5, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, September 5, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, September 5, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, September 5, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, October 3, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, October 3, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sunday, October 5, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 29, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 4, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 4, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |